Next-generation cancer vaccines and emerging immunotherapy combinations
Trends in Cancer · 2024
DOI: 10.1016/j.trecan.2024.06.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2024. Verfasst von Anne Brandenburg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic III of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms, Immune Checkpoint Inhibitors, Immunotherapy. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 171 Literaturangaben.
Abstract (Originalsprache)
Therapeutic cancer vaccines have been a subject of research for several decades as potential new weapons to tackle malignancies. Their goal is to induce a long-lasting and efficient antitumour-directed immune response, capable of mediating tumour regression, preventing tumour progression, and eradicating minimal residual disease, while avoiding major adverse effects. Development of new vaccine technologies and antigen prediction methods has led to significant improvements in cancer vaccine efficacy. However, for their successful clinical application, certain obstacles still need to be overcome, especially tumour-mediated immunosuppression and escape mechanisms. In this review, we introduce therapeutic cancer vaccines and subsequently discuss combination approaches of next-generation cancer vaccines and existing immunotherapies, particularly immune checkpoint inhibitors (ICIs) and adoptive cell transfer/cell-based immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Clinic III of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany.
- Medical Clinic III of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany. Electronic address: Peter.Brossart@ukbonn.de.
Zitieren
APA
Brandenburg, A., Heine, A., & Brossart, P. (2024). Next-generation cancer vaccines and emerging immunotherapy combinations. Trends in Cancer. https://doi.org/10.1016/j.trecan.2024.06.003
Vancouver
Brandenburg A, Heine A, Brossart P. Next-generation cancer vaccines and emerging immunotherapy combinations. Trends in Cancer. 2024. doi:10.1016/j.trecan.2024.06.003
BibTeX
@article{Brandenburg2024,
author = {Brandenburg, Anne and Heine, Annkristin and Brossart, Peter},
title = {Next-generation cancer vaccines and emerging immunotherapy combinations},
journal = {Trends in Cancer},
year = {2024},
doi = {10.1016/j.trecan.2024.06.003}
}
EUVIMED